CXCL12 and hepatocellular carcinoma: Our findings indicate that ephrinA1/EphA1 pathway activation in HCC cells can promote tumor angiogenesis by enhancing the homing and tube formation abilities of EPCs in a paracrine fashion, and targeting the EphA1/SDF-1 signaling pathway might be a therapeutic anti-angiogenesis approach for treating HCC.